The Neutrophil-lymphocyte ratio in patients with community-acquired pneumonia

t. amir (tunis, Tunisia), S. Toujani (tunis, Tunisia), S. Ben Khaled (tunis, Tunisia), A. Slim (tunis, Tunisia), A. Hedhli (tunis, Tunisia), S. Cheikhrouhou (tunis, Tunisia), Y. Ouahchi (tunis, Tunisia), M. Mjid (tunis, Tunisia), S. Merai (tunis, Tunisia)

Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Session: Predicting the future: biomarkers of respiratory infection
Session type: Thematic Poster
Number: 2620
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
t. amir (tunis, Tunisia), S. Toujani (tunis, Tunisia), S. Ben Khaled (tunis, Tunisia), A. Slim (tunis, Tunisia), A. Hedhli (tunis, Tunisia), S. Cheikhrouhou (tunis, Tunisia), Y. Ouahchi (tunis, Tunisia), M. Mjid (tunis, Tunisia), S. Merai (tunis, Tunisia). The Neutrophil-lymphocyte ratio in patients with community-acquired pneumonia. 2620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The neutrophil-lymphocyte count ratio in patients with hospital-acquired pneumonia
Source: International Congress 2019 – Recent developments in intensive care unit medicine
Year: 2019

The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Is Neutrophil-lymphocyte ratio useful for differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018


Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006

Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

C-reactive protein in community-acquired pneumonia
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression
Source: Eur Respir J 2012; 40: 1201-1210
Year: 2012



Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012

Community-acquired pneumonia requiring hospitalization in HIV-infected patients
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
Source: Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020
Year: 2020



Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

Correlation between pneumonia severity index and mortality within 30 days after the diagnosis of community-acquired pneumonia in elderly subjects
Source: Eur Respir J 2006; 28: Suppl. 50, 741s
Year: 2006

Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009